Accurate Identification Of Skin Cancer Using High-Frequency Ultrasound With Elastography

According to a latest study, high-frequency ultrasound with elastography could assist in differentiating malignant disorders from harmless skin conditions.

Eliot L. Siegel, M.D., the lead author stated that high-frequency ultrasound with elastography had the likelihood of enhancing diagnosis of skin cancer by effectively delineating the size of the lesions and could offer quantifiable segregation amongst an assortment of harmless and cancerous skin lesions.

According to the American Cancer Society an annual skin cancer diagnosis in the United States has surpassed a million cases. Melanoma, being the gravest form of skin cancer that constitutes nearly close to sixty-nine thousand skin cancer cases and nearly twelve thousand fatalities in 2009, in spite of the fact that with early diagnosis it could be majorly cured.

Dubious skin lesions are characteristically identified by dermatologists and biopsies are done on the basis of their surface appearance and type. Regrettably, even to the highly trained eye, the analogous ocular appearance of benign and malignant lesions and at times malignant lesions mostly appearing benign particularly in their preliminary stages could be puzzling. Hence, it is not unusual for patients to be having one or more lesions that appear worrisome.

Skin specialists have a tendency of biopsying any lesions that appear dubious, thus as an outcome several non-malignant lesions are unnecessarily biopsied in order to avert the risk of overlooking a probably lethal melanoma.

Elastography was observed to differentiate between harmless and cancerous skin lesions by carrying out a measurement of their elasticity or firmness and not by their ocular appearance. As cancerous growths are firmer as compared to the benign ones, elastography when used as an adjunct to high-frequency ultrasound imaging of the skin had the likelihood of enhancing the correctness of conventional clinical identification of skin cancers and in certain circumstances, eradicate redundant biopsies of non-malignant skin lesions. The method is non-invasive, expedient and cost-effective.

During the study, the researchers employed an ultra high-frequency ultrasound system for imaging forty patients with an array of cancerous and non-cancerous skin lesions. Cancerous tumors like squamous cell skin cancer, basal cell skin cancer and melanoma. Non-cancerous lesions comprise of dermatofibroma –a non-cancerous growth that contains scar tissue and lipoma – a non-malignant tumor made up of fatty tissue.

The researchers computed the proportion of elasticity in between healthy skin and the adjoining skin lesions and employed lab evaluation for corroborating their identifications. Cystic lesions that are non-cancerous, illustrated elevated elasticity levels whereas cancerous lesions showed considerably lesser elasticity. The elasticity proportion of healthy skin to the varied skin lesions were in the ranges 0.04-0.3 in case of cystic skin lesions to more than ten in case of cancerous lesions.

Additionally, high-frequency ultrasound with elastography facilitates precise categorization of the size and how deep the lesion lies beneath the skin’s surface that could better assist doctors for treating the patients.

Researchers explained that the envisaged part of the skin lesion could merely be the start of much to be unravelled and majority of the dermatologists function impetuously past what they could observe exteriorly. High-frequency ultrasound offers nearly microscopic resolution enabling to achieve extent and mass of the lesion before biopsy.

Popularity: 21% [?]